Profit

See Value In Pharma Stocks: Andrew Holland

PUBLISHED ON: July 26, 2016 | Duration: 24 min, 53 sec

  
loading..
Andrew Holland, CEO of Ambit Investment Advisors, says value has emerged in pharma sector in a month or so after FDA inspections and rulings. Pharms stocks are ripe for re-rating and within that re-rating there will be a switch back to the pharma sector from IT sector, added Mr Holland.
ALSO WATCH
Money Moving From Real Estate Into Equities, Says Saurabh Mukherjea

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com